治験レーダーAI | ||
|---|---|---|
治験 NCT00162175(対象:Metabolics Diabetes Nos)は完了です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。 | ||
PPAR-COMBO With Sulfonylurea 第III相・フェーズ3 534 無作為化 二重盲検 プラセボ対照
A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Glyburide Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone
- CV168-021
| 参加グループ/群 | 介入/治療法 |
|---|---|
該当なし | Muraglitazar |
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Compare change from baseline in HbA1c after 24 weeks of treatment with muraglitazar + glyburide vs placebo + glyburide |
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Change in FPG from basline to W24, proportion of subjects receiving therapeutic response at W24, percent change of fasting lipid levels from baseline to W11/12, change in hs-CRP from baseline to W24 |
- Type 2 Diabetes, HbA1c > 7.0% and < 10.0%, mean serum triglyceride < 600 mg/dL, body mass index < 41 kg/m2, fasting c-peptide . 1.5 ng/mL.
- History of MI (myocardial infarction), coronary angioplasty or bypass graft(s), valvular disease or repair, unstable angina pectoris, transient ischemic attack (TIA), cerebrovascular attack, or cerebrovascular accident (CVA) within 6 months, congestive heart failure (NYHA Class III and IV, uncontrolled hypertension, history or renal disease, peripheral vascular disease (PVD), pulmonary disease, gastrointestinal disease, active liver disease or endocrine disease.
Alabama
Arizona
Arkansas
California
Colorado
Florida
Georgia
Illinois
Kansas
Kentucky
Louisiana
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
New York
North Carolina
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
Tennessee
Texas
Washington
West Virginia
Wisconsin
Buenas Aires
Buenos Aires
Córdoba Province
Mendoza Province
New South Wales
Queensland
Paraná
Pará
Rio Grande do Sul
São Paulo
Ontario
Quebec
D'Egletons
Sur Leze
Wesserling
Schwenningen
Durango
Estado de Baja California
Guanajuato
Mexico City
New Mexico
Nuevo León
Yucatán
Arequipa
Lima Province
De Compostela
DE
Cambridgeshire
East Sussex
Greater London
Hampshire
Lanarkshire
Lancashire
Middlesex
Sussex
Wiltshire
Worcestershire